156 related articles for article (PubMed ID: 11682143)
1. Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs.
Nishino S; Fujiki N; Ripley B; Sakurai E; Kato M; Watanabe T; Mignot E; Yanai K
Neurosci Lett; 2001 Nov; 313(3):125-8. PubMed ID: 11682143
[TBL] [Abstract][Full Text] [Related]
2. Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy.
Mishima K; Fujiki N; Yoshida Y; Sakurai T; Honda M; Mignot E; Nishino S
Sleep; 2008 Aug; 31(8):1119-26. PubMed ID: 18714784
[TBL] [Abstract][Full Text] [Related]
3. Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog.
Fujiki N; Yoshida Y; Ripley B; Mignot E; Nishino S
Sleep; 2003 Dec; 26(8):953-9. PubMed ID: 14746374
[TBL] [Abstract][Full Text] [Related]
4. Narcolepsy: biogenic amine deficits in an animal model.
Mefford IN; Baker TL; Boehme R; Foutz AS; Ciaranello RD; Barchas JD; Dement WC
Science; 1983 May; 220(4597):629-32. PubMed ID: 6188216
[TBL] [Abstract][Full Text] [Related]
5. Interactions of the orexin/hypocretin neurones and the histaminergic system.
Sundvik M; Panula P
Acta Physiol (Oxf); 2015 Feb; 213(2):321-33. PubMed ID: 25484194
[TBL] [Abstract][Full Text] [Related]
6. CNS monoamines and their metabolites in canine narcolepsy: a replication study.
Miller JD; Faull KF; Bowersox SS; Dement WC
Brain Res; 1990 Feb; 509(1):169-71. PubMed ID: 1689603
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin levels in sporadic and familial cases of canine narcolepsy.
Ripley B; Fujiki N; Okura M; Mignot E; Nishino S
Neurobiol Dis; 2001 Jun; 8(3):525-34. PubMed ID: 11442359
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.
Hungs M; Fan J; Lin L; Lin X; Maki RA; Mignot E
Genome Res; 2001 Apr; 11(4):531-9. PubMed ID: 11282968
[TBL] [Abstract][Full Text] [Related]
9. Sleep, sleep disorders and hypocretin (orexin).
Mignot E
Sleep Med; 2004 Jun; 5 Suppl 1():S2-8. PubMed ID: 15301991
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of TAC1, PENK and SOCS2 in Hcrtr-2 mutated narcoleptic dog brain.
Lindberg J; Saetre P; Nishino S; Mignot E; Jazin E
BMC Neurosci; 2007 May; 8():34. PubMed ID: 17521418
[TBL] [Abstract][Full Text] [Related]
11. Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons.
Kalogiannis M; Grupke SL; Potter PE; Edwards JG; Chemelli RM; Kisanuki YY; Yanagisawa M; Leonard CS
Eur J Neurosci; 2010 Jul; 32(1):130-42. PubMed ID: 20576035
[TBL] [Abstract][Full Text] [Related]
12. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.
Lin L; Faraco J; Li R; Kadotani H; Rogers W; Lin X; Qiu X; de Jong PJ; Nishino S; Mignot E
Cell; 1999 Aug; 98(3):365-76. PubMed ID: 10458611
[TBL] [Abstract][Full Text] [Related]
13. I. Mutation in the hypocretin (orexin) receptor 2 gene causes canine narcolepsy.
Reilly CE
J Neurol; 1999 Oct; 246(10):985-6. PubMed ID: 10552257
[No Abstract] [Full Text] [Related]
14. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.
Peyron C; Faraco J; Rogers W; Ripley B; Overeem S; Charnay Y; Nevsimalova S; Aldrich M; Reynolds D; Albin R; Li R; Hungs M; Pedrazzoli M; Padigaru M; Kucherlapati M; Fan J; Maki R; Lammers GJ; Bouras C; Kucherlapati R; Nishino S; Mignot E
Nat Med; 2000 Sep; 6(9):991-7. PubMed ID: 10973318
[TBL] [Abstract][Full Text] [Related]
15. Increase of histaminergic tuberomammillary neurons in narcolepsy.
Valko PO; Gavrilov YV; Yamamoto M; Reddy H; Haybaeck J; Mignot E; Baumann CR; Scammell TE
Ann Neurol; 2013 Dec; 74(6):794-804. PubMed ID: 24006291
[TBL] [Abstract][Full Text] [Related]
16. Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.
Gerashchenko D; Salin-Pascual R; Shiromani PJ
Brain Res; 2001 Sep; 913(1):106-15. PubMed ID: 11532254
[TBL] [Abstract][Full Text] [Related]
17. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy.
Wu MF; Nienhuis R; Maidment N; Lam HA; Siegel JM
J Neurosci; 2011 Apr; 31(17):6305-10. PubMed ID: 21525270
[TBL] [Abstract][Full Text] [Related]
18. The roles of midbrain and diencephalic dopamine cell groups in the regulation of cataplexy in narcoleptic Dobermans.
Okura M; Fujiki N; Kita I; Honda K; Yoshida Y; Mignot E; Nishino S
Neurobiol Dis; 2004 Jun; 16(1):274-82. PubMed ID: 15207284
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy and the hypocretin receptor 2 gene.
Aldrich MS; Reynolds PR
Neuron; 1999 Aug; 23(4):625-6. PubMed ID: 10482224
[No Abstract] [Full Text] [Related]
20. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
